Prospective cohort study on clinical pharmacist involvement in the management of opioid use after orthopedic surgery under the enhanced recovery after surgery model

YANG Yumin; LI Xiumin; WANG Lu

doi:10.6039/j.issn.1001-0408.2025.12.15

您当前的位置：

首页 >

文章列表页 >

Prospective cohort study on clinical pharmacist involvement in the management of opioid use after orthopedic surgery under the enhanced recovery after surgery model

更新时间：2025-09-23

- Prospective cohort study on clinical pharmacist involvement in the management of opioid use after orthopedic surgery under the enhanced recovery after surgery model
- ZHONGGUO YAOFANG Vol. 36, Issue 12, Pages: 1505-1510(2025)
- 作者机构：
  
  1.解放军总医院医疗保障中心药剂科，北京　100700
  2.保定市第一中心医院药学部，河北保定　071000
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2025.12.15
  CLC： R971;R969.3
- Received：04 January 2025，
  
  Revised：2025-05-22，
  
  Accepted：26 May 2025，
  
  Published：30 June 2025
- 稿件说明：
移动端阅览
杨玉敏,李秀敏,王璐.加速康复外科模式下临床药师参与骨科术后阿片类药物使用管理的前瞻性队列研究 [J].中国药房,2025,36(12):1505-1510.

YANG Yumin,LI Xiumin,WANG Lu.Prospective cohort study on clinical pharmacist involvement in the management of opioid use after orthopedic surgery under the enhanced recovery after surgery model[J].ZHONGGUO YAOFANG,2025,36(12):1505-1510.
杨玉敏,李秀敏,王璐.加速康复外科模式下临床药师参与骨科术后阿片类药物使用管理的前瞻性队列研究 [J].中国药房,2025,36(12):1505-1510. DOI： 10.6039/j.issn.1001-0408.2025.12.15.

YANG Yumin,LI Xiumin,WANG Lu.Prospective cohort study on clinical pharmacist involvement in the management of opioid use after orthopedic surgery under the enhanced recovery after surgery model[J].ZHONGGUO YAOFANG,2025,36(12):1505-1510. DOI： 10.6039/j.issn.1001-0408.2025.12.15.

摘要

目的

为改善术后患者疼痛管理成效、加速患者康复、确保阿片类药物使用安全提供参考。

方法

采用前瞻性队列研究方法，将2021年11月－2023年11月在保定市第一中心医院（下称“我院”）骨科接受择期髋膝关节置换术的患者按随机数字表法分为对照组和观察组，每组178例。对照组患者接受由医护人员按照我院骨科围手术期疼痛治疗临床路径实施的术后疼痛管理，观察组患者在加速康复外科模式下，接受由含临床药师参与的多学科协作团队提供的术后疼痛管理。比较两组患者术后阿片类药物相关问题（DRPs）的发生及解决情况，并利用欧洲医药保健网分类系统9.1版对两组患者存在的DRPs进行分类分析；比较两组患者术后疼痛评分、睡眠质量评分、住院时间及不良反应发生情况。

结果

两组患者共存在阿片类药物DRPs 162个，其中观察组58个（涉及52例患者）、对照组104个（涉及91例患者），差异有统计学意义（

＜0.05）；两组DRPs涉及问题均以治疗有效性为主。观察组临床药师对发现的58个阿片类药物DRPs进行了88次干预，总体干预成功率为84.5%。观察组患者术后1～7 d的疼痛评分和睡眠质量评分、髋关节置换术住院时间及平均住院时间、阿片类药物总不良反应发生率均显著低于或短于对照组（

＜0.05）；且两组患者疼痛评分和睡眠质量评分的主时间效应、时间及组别交互作用均显著（

＜0.05），即对照组相关评分减少更多，观察组相关评分改善更为迅速。

结论

临床药师全程参与骨科术后疼痛治疗及阿片类药物管理，可及时识别并干预DRPs，提高术后镇痛效果，减少不良反应，缩短住院时间，加速患者术后康复。

Abstract

OBJECTIVE

To provide a reference for improving postoperative pain management outcomes， accelerating patient recovery， and ensuring the safe use of opioids.

METHODS

A prospective cohort study was conducted， in which patients undergoing elective hip or knee replacement in the Department of Orthopedics at Baoding No.1 Central Hospital （hereinafter referred to as “our hospital”） from November 2021 to November 2023 were randomly divided into control group and observation group using a random number table， with 178 cases in each group. Patients in the control group received postoperative pain management implemented by medical staff according to the clinical pathway for perioperative pain treatment. Patients in the observation group， under the enhanced recovery after surgery model， received postoperative pain management through a multidisciplinary collaborative team including clinical pharmacists. The occurrence and resolution of opioid-related drug-related problems （DRPs） were compared between the two groups， and the DRPs were classified and analyzed using the Pharmaceutical Care Network Europe Classification System （V9.1）. Postoperative pain scores， sleep quality scores， length of hospital stay， and incidence of adverse reactions were compared between the two groups.

RESULTS

A total of 162 opioid-related DRPs were identified in 2 groups， with 58 in the observation group （identified 52 patients） and 104 in the control group （identified 91 patients）， showing a statistically significant difference （

＜0.05）. The primary issue involved in the DRPs for both groups was therapeutic effectiveness. Clinical pharmacists in the observation group conducted 88 interventions for the identified 58 opioid-related DRPs， achieving an overall intervention success rate of 84.5%. The pain scores and sleep quality scores from postoperative day 1 to 7， the length of hospitalization for hip replacement， the average hospitalization duration， and the total incidence of opioid-related adverse reactions were all significantly lower or shorter in the observation group compared to the control group （

＜0.05）. Furthermore， the main time effect， time-group interaction effect for pain scores and sleep q

uality scores were statistically significant in both groups （

＜0.05）， indicating that the control group exhibited greater reductions in these scores and observation group exhibited more rapid improvements.

CONCLUSIONS

The full involvement of clinical pharmacists in postoperative pain management and opioid medication administration in the orthopedics department enables timely identification and intervention of DRPs， enhance postoperative analgesia efficacy， decrease adverse drug reactions， shorten hospital stays， and accelerate patient recovery.

关键词

Keywords

references

KONNYU K J ， THOMA L M ， CAO W N ， et al . Prehabilitation for total knee or total hip arthroplasty：a systematic review [J ] . Am J Phys Med Rehabil ， 2023 ， 102 （ 1 ）： 1 - 10 .

LEBLEU J ， PAUWELS A ， POILVACHE H ， et al . Severe postoperative pain in total knee arthroplasty patients：risk factors，insights and implications for pain management via a digital health approach [J ] . J Clin Med ， 2023 ， 12 （ 24 ）： 7695 .

MULLEN M A ， KIM K W ， PROCACCINI M ， et al . Postoperative opioid prescribing practices and patient opioid utilization in pediatric orthopaedic surgery patients [J ] . J Pediatr Orthop ， 2024 ， 44 （ 1 ）： e91 - e96 .

LANDES E K ， LEUCHT P ， TEJWANI N C ， et al . Decreasing postoperative opioid prescriptions after ortho-pedic trauma surgery：the “lopioid” protocol [J ] . Pain Med ， 2022 ， 23 （ 10 ）： 1639 - 1643 .

CHOI Y S ， KIM T W ， CHANG M J ， et al . Enhanced recovery after surgery for major orthopedic surgery：a narrative review [J ] . Knee Surg Relat Res ， 2022 ， 34 （ 1 ）： 8 .

CHEUNG C K ， ADEOLA J O ， BEUTLER S S ， et al . Postoperative pain management in enhanced recovery pathways [J ] . J Pain Res ， 2022 ， 15 ： 123 - 135 .

SCHINDLER E ， RICHLING I ， ROSE O . Pharmaceutical Care Network Europe （PCNE） drug-related problem classification version 9.00：German translation and validation [J ] . Int J Clin Pharm ， 2021 ， 43 （ 3 ）： 726 - 730 .

BUYSSE D J ， REYNOLDS C F ， MONK T H ， et al . The Pittsburgh sleep quality index：a new instrument for psychiatric practice and research [J ] . Psychiatry Research ， 1989 ， 28 （ 2 ）： 193 - 213 .

LIU S ， STEVENS J A ， COLLINS A E ， et al . Prevalence and predictors of long-term opioid use following ortho-paedic surgery in an Australian setting：a multicentre，pro-spective cohort study [J ] . Anaesth Intensive Care ， 2023 ， 51 （ 5 ）： 321 - 330 .

XIE H ， WANG X M ， XUE M ， et al . Effectiveness and safety of path-based analgesic regimens designed by clinical pharmacists based on the type of biliary and pancreatic surgery [J ] . J Clin Pharm Ther ， 2022 ， 47 （ 12 ）： 2302 - 2311 .

卢钧雄，刘瑜，王若伦 . 临床药师在肝胆外科术后急性疼痛管理中的作用及工作实践 [J ] . 中国医院药学杂志， 2019 ， 39 （ 20 ）： 2099 - 2102，2106 .

GORMLEY J ， GOUVEIA K ， SAKHA S ， et al . Reduction of opioid use after orthopedic surgery：a scoping review [J ] . Can J Surg ， 2022 ， 65 （ 5 ）： E695 - E715 .

CHUNDURI A ， AGGARWAL A K . Multimodal pain mana-gement in orthopedic surgery [J ] . J Clin Med ， 2022 ， 11 （ 21 ）： 6386 .

BJURSTRÖM M F ， IRWIN M R ， BODELSSON M ， et al . Preoperative sleep quality and adverse pain outcomes after total hip arthroplasty [J ] . Eur J Pain ， 2021 ， 25 （ 7 ）： 1482 - 1492 .

WOOD T J ， GAZENDAM A M ， KABALI C B ， et al . Postoperative outcomes following total hip and knee arthroplasty in patients with pain catastrophizing，anxiety，or depression [J ] . J Arthroplasty ， 2021 ， 36 （ 6 ）： 1908 - 1914 .

MATHIS D T ， HAUSER A ， IORDACHE E ， et al . Typical pain patterns in unhappy patients after total knee arthroplasty [J ] . J Arthroplasty ， 2021 ， 36 （ 6 ）： 1947 - 1957 .

RLER H G ， FATMA TOK Y L Z ， BEKMEZ F . A common complication in orthopedic patients：postoperative constipation and related risk factors [J ] . J Perianesth Nurs ， 2023 ， 38 （ 5 ）： e15 - e20 .

WANG X Y ， NARAYAN S W ， PENM J ， et al . Gastrointestinal adverse events in hospitalized patients following orthopedic surgery：tapentadol immediate release versus oxycodone immediate release [J ] . Pain Physician ， 2021 ， 24 （ 3 ）： E309 - E315 .

XU X D ， TAO Y ， YANG Y T ， et al . Application of butorphanol versus sufentanil in multimode analgesia via patient controlled intravenous analgesia after hepatobiliary surgery：a retrospective cohort study [J ] . Drug Des Devel Ther ， 2023 ， 17 ： 3757 - 3766 .

AL-QURAIN A A ， GEBREMICHAEL L G ， KHAN M S ， et al . Opioid prescribing and risk of drug-opioid interactions in older discharged patients with polypharmacy in Australia [J ] . Int J Clin Pharm ， 2021 ， 43 （ 2 ）： 365 - 374 .

CRAWFORD A M ， STRIANO B M ， GONG J ， et al . Validation of the stopping opioids after surgery（SOS）score for the sustained use of prescription opioids following orthopaedic surgery [J ] . J Bone Joint Surg Am ， 2023 ， 105 （ 18 ）： 1403 - 1409 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

One case report and literature review of severe cardiotoxicity by oxaliplatin combined with capecitabine

Pharmaceutical care in a patient with hemorrhagic transformation after cerebral infarction complicated with atrial fibrillation

Pharmaceutical care of reactivating anthracycline chemotherapy in a patient with advanced breast cancer combined with thyroid cancer

Pharmaceutical care for a patient with rhino-orbito-cerebral mucormycosis

Rational use management standards of national key monitoring drug

Related Author

XU Lina

FANG Yingli

WANG Xiangling

DU Pengcheng

GAO Ling

YUAN Jing

QIN Wenjie

ZHU Bin

Related Institution

Dept. of Oncology， Qilu Hospital of Shandong University

Dept. of Clinical Pharmacy， Dezhou Hospital， Qilu Hospital of Shandong University

Dept. of Clinical Pharmacy， Qilu Hospital of Shandong University

Dept. of Pharmacy， the Hospital of Joint Logistics Support Force

Dept. of Pharmacy， Hunan Provincial People’s Hospital

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰